| Literature DB >> 29279377 |
Bing Chen1, Lu Jiang1, Meng-Ling Zhong1, Jian-Feng Li1, Ben-Shang Li2, Li-Jun Peng1, Yu-Ting Dai1, Bo-Wen Cui1, Tian-Qi Yan1, Wei-Na Zhang1, Xiang-Qin Weng1, Yin-Yin Xie1, Jing Lu1, Rui-Bao Ren1, Su-Ning Chen3, Jian-Da Hu4, De-Pei Wu3, Zhu Chen5, Jing-Yan Tang6, Jin-Yan Huang5, Jian-Qing Mi5, Sai-Juan Chen5.
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is a clonal malignancy of immature T cells. Recently, the next-generation sequencing approach has allowed systematic identification of molecular features in pediatric T-ALL. Here, by performing RNA-sequencing and other genomewide analysis, we investigated the genomic landscape in 61 adult and 69 pediatric T-ALL cases. Thirty-six distinct gene fusion transcripts were identified, with SET-NUP214 being highly related to adult cases. Among 18 previously unknown fusions, ZBTB16-ABL1, TRA-SALL2, and involvement of NKX2-1 were recurrent events. ZBTB16-ABL1 functioned as a leukemogenic driver and responded to the effect of tyrosine kinase inhibitors. Among 48 genes with mutation rates >3%, 6 were newly found in T-ALL. An aberrantly overexpressed short mRNA transcript of the SLC17A9 gene was revealed in most cases with overexpressed TAL1, which predicted a poor prognosis in the adult group. Up-regulation of HOXA, MEF2C, and LYL1 was often present in adult cases, while TAL1 overexpression was detected mainly in the pediatric group. Although most gene fusions were mutually exclusive, they coexisted with gene mutations. These genetic abnormalities were correlated with deregulated gene expression markers in three subgroups. This study may further enrich the current knowledge of T-ALL molecular pathogenesis.Entities:
Keywords: T-ALL; ZBTB16-ABL1; fusion gene; gene mutation; transcriptome
Mesh:
Substances:
Year: 2017 PMID: 29279377 PMCID: PMC5777070 DOI: 10.1073/pnas.1717125115
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205